Aaf M. Kuijper - Publications

Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: September 03, 2024

Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.

Journal: European journal of heart failure

Published: April 05, 2024

Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial.

Journal: JACC. Clinical electrophysiology

Published: September 21, 2023

Colchicine in Patients with Chronic Coronary Disease.

Journal: The New England journal of medicine

Published: September 01, 2020

Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugs.

Journal: International journal of medical informatics

Published: March 24, 2020

Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.

Journal: International journal of clinical pharmacy

Published: January 10, 2018

Risk factors for QTc interval prolongation.

Journal: European journal of clinical pharmacology

Published: May 12, 2017

A new approach to determine the results of minimally invasive pulmonary vein isolation using a continuous loop monitor: preliminary results.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: September 16, 2014